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Abstract
Toll-like receptors (TLR) are key players of the innate and adaptive immune response in vertebrates. The original protein Toll
in Drosophila melanogaster regulates both host defense and morphogenesis during development. Making use of real-time
PCR, in situ hybridization, and immunohistochemistry we systematically examined the expression of TLR1–9 and the
intracellular adaptor molecules MyD88 and TRIF during development of the mouse brain. Expression of TLR7 and TLR9 in
the brain was strongly regulated during different embryonic, postnatal, and adult stages. In contrast, expression of TLR1–6,
TLR8, MyD88, and TRIF mRNA displayed no significant changes in the different phases of brain development. Neurons of
various brain regions including the neocortex and the hippocampus were identified as the main cell type expressing both
TLR7 and TLR9 in the developing brain. Taken together, our data reveal specific expression patterns of distinct TLRs in the
developing mouse brain and lay the foundation for further investigation of the pathophysiological significance of these
receptors for developmental processes in the central nervous system of vertebrates.
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Introduction
Toll was identified as a regulator of the dorsoventral axis
polarity during embryogenesis of Drosophila melanogaster [1].
Subsequently, it was found to play a key role in the fly’s immune
response [2]. The orthologs of Toll in vertebrates, the Toll-like
receptors (TLRs), are innate immune receptors that detect both
highly conserved pathogen-associated molecular patterns and
host-derived molecules released during tissue damage. All of the
known TLRs bind to adaptor proteins, among which myeloid
differentiation primary response protein 88 (MyD88) and Toll/IL-
1 receptor (TIR) domain-containing adaptor inducing IFN-b
(TRIF) are key to subsequent activation of the intracellular
signaling cascades that ultimately cause the release of inflamma-
tory molecules from immune cells [3]. TLRs are abundantly
expressed in the peripheral immune system but are also present in
the central nervous system (CNS) where they mediate both
immunological functions and responses to injury [4,5]. Microglia,
the major immune cells of the brain, express the full repertoire of
TLRs, but some of these receptors are also present in neurons.
However, the functional implications of TLR expression in
neurons are not fully understood yet. Experimental evidence
suggests that distinct TLRs regulate neural plasticity and
development in neurons [6]. For example, TLR3 inhibits neural
progenitor cell proliferation in the embryonic mouse telenceph-
alon and regulates axonal growth [7,8]. In addition, TLR8 is
involved in injury and neurite outgrowth associated with neural
development [9]. Finally TLR2 and TLR4 play a role in adult
neurogenesis of the hippocampus [10,11]. A role of TLRs in brain
development and morphogenesis of vertebrates beyond these
specific settings is mostly unknown. Although endogenous ligands
of TLRs including extracellular matrix proteins and heat shock
proteins exist, the host-derived molecules stimulating TLRs in the
context of CNS development remain unidentified [12].
In this study we systematically characterize the expression of
TLR1–9 as well as of MyD88 and TRIF during pre- and postnatal
development of the mouse brain. CNS neurons of mouse embryos
and newborns upregulate TLR7 transiently around birth. In
contrast, expression of TLR9 increases constantly during late
embryogenesis and postnatal stages until adult levels are reached.
Although not found being statistically significant, TLR1, TLR3,
and TLR6 expression also tend to follow a development-
dependent pattern. Expression of other TLR family members
and of MyD88 and TRIF was low and did not change significantly
during the analyzed time period. The fact that distinct TLRs exert
specific expression patterns over time in the developing mouse
brain suggests a physiological relevance of specific TLRs in
vertebrates in brain development.
Results
mRNA expression of TLRs, in particular TLR7 and TLR9, in
the mouse brain correlates with different developmental
stages
To systematically characterize the expression of the members of
the TLR family in the mammalian developing brain, brains from
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quantitative real-time PCR using primers specific for TLR1–9,
MyD88, and TRIF. Time points of brain sampling were
embryonic days E13–19, P0, postnatal days P4, P8, and P12 as
well as the age of 5 months (P5m) (Fig. 1). Expression of TLR7 and
TLR9 mRNA displayed significant changes during the analyzed
periods. In detail, TLR7 mRNA expression was detectable in the
brain as early as E13, increased on E18, and reached an almost
40-fold induction on P4 compared to embryonic stages. After P4
TLR7 expression decreased during the postnatal period to the low
abundance found in the adult brain. Expression of TLR9 mRNA
increased continuously during embryogenesis and postnatal stages
until a 13-fold induction compared to embryonic stages was
reached at an adult age. Although not statistically significant,
expression of several other TLRs also seemed to follow a specific
development-dependent pattern. For example, whereas expression
of TLR1 tended to be increased around birth and on P12, TLR3
expression seemed to reach higher levels on P0 and P8 compared
to embryonic stages. TLR6 expression revealed by trend an
increased level around birth. In contrast to these receptors,
expression of TLR2, TLR4, TLR5, TLR8, MyD88, and TRIF
mRNA was low during the whole analyzed period.
TLR7 and TLR9 mRNA are expressed in neurons of the
developing mouse brain
Having observed that expression of TLR7 and TLR9 mRNA is
regulated during brain development, we investigated in which
brain regions and in which cell types of the developing brain
TLR7 and TLR9 are expressed. To this end, brain sections from
mice of embryonic, perinatal, and adult stages were analyzed by in
situ hybridization using specific probes for TLR7 and TLR9. Both
TLR7 (Fig. 2A) and TLR9 (Fig. 2B) mRNA were readily
detectable in various regions of the murine brain, including the
hippocampus and the neocortex. In keeping with our findings
using the quantitative real-time PCR analysis described above,
TLR7 mRNA expression increased from embryonic to postnatal
stages and then decreased to lower expression levels in the adult
brain (Fig. 2C). Likewise, TLR9 mRNA expression continuously
increased during embryonic and postnatal stages until adult levels
were achieved (Fig. 2D), resembling the PCR results described
above. Specificity of the employed TLR7 and TLR9 in situ
hybridization probes were confirmed by including negative control
probes with a scrambled sequence (Fig. 2C,D) and by analyzing
comparable sections from TLR7- and TLR9-deficient mice,
respectively (Fig. 2E). Parallel immunostaining of adjacent sections
of the neocortex with a NeuN antibody identified most of the
TLR7-positive (Fig. 2F) and TLR9-positive (Fig. 2G) cells as
neurons.
Expression of TLR7 protein in CNS neurons is increased
perinatally
Immunohistochemistry using a TLR7 antibody revealed abun-
dant expression of TLR7 protein in various regions of the brain
(Fig. 3). TLR7 protein was mainly detected in neurons, as judged
by morphological analysis (Fig. 3). Expression of TLR7 protein in
the neocortex increased during brain development and reached a
peak during early postnatal phases (Fig. 4A). Confocal microscopy
of brain sections co-immunostained with a NeuN antibody
displayed expression of TLR7 protein in neurons of the neocortex,
particularly in those associated with the layers II and III, as
expected from the RNA studies described above (Fig. 4B).
Specificity of the anti-TLR7 antibody was confirmed by
demonstrating its reactivity with HEK293 cells transfected with
TLR7 (Fig. 4C) and by analyzing comparable brain sections from
TLR7-deficient mice (Fig. 4D).
Expression of TLR7 in axons in the developing brain
TLR7 protein was mainly detected in neuronal cell bodies of the
neocortex and the hippocampus, but isolated elongated structures,
which were judged as axons morphologically, in various brain
regions also stained positive for TLR7 at different developmental
stages. In particular, these TLR7-positive axons, partially bundled
as tracts, were present in the caudal putamen, dorso-lateral
septum, fimbria-fornix system as well as the corpus callosum
(Fig. 5A). As observed for neuronal cell bodies, expression of
TLR7 protein in these axons varied depending on the develop-
mental stage. Whereas no or low levels of TLR7-positive axons
were observed in the respective brain regions of sections derived
from adult mice, marked expression was found in the same regions
of sections from mice at early postnatal stages (Fig. 5A). Brain
sections from P12 mice were co-immunostained with antibodies
against TLR7 and neurofilament. Analysis by confocal microscopy
revealed that the axons positive for TLR7 did not co-localize with
the neurofilament antibody, but were instead nestling between
neurofilament-positive axons, which did not express TLR7.
However, some very few punctiform structures positive for both
neurofilament and TLR7 antibody were observed and interpreted
as crossovers of the two named groups of axons (Fig. 5B). Likewise,
immunostaining of the brain sections with the MAP-2 antibody,
an established marker for dendrites, did not result in co-
localization with TLR7 (data not shown). In order to rule out
that these isolated extended structures were extensions from other
CNS cells than neurons, brain sections from P12 mice were co-
immunostained with antibodies against TLR7 and GFAP, RIP, or
Iba1 antibodies to mark astrocytes, oligodendrocytes and microg-
lia, respectively (Fig. 5C). As expected, TLR7 in the axon-like
structures did not co-localize with any of the glial markers named
above. In contrast, cell bodies of microglia were positive for both
TLR7 and Iba1 (Fig. 5C), as expected.
In summary, TLR7 is expressed in neurons and neurofilament-
negative axons in the developing mouse brain, particularly in the
early postnatal phase.
Expression of TLR9 protein in neurons of the CNS
increases with advancing age
Immunohistochemistry revealed an increased expression of
TLR9 protein in the hippocampus and the neocortex of adult
mouse stages compared to postnatal stages (Fig. 6A), resembling
the PCR findings reported above.
Co-immunostaining of brain sections from adult animals with a
MAP-2 antibody and subsequent analysis by confocal microscopy
localized TLR9 protein to neuronal cell bodies and dendrites in
Figure 1. Expression of TLR1–9 mRNA, MyD88 mRNA, and TRIF mRNA in the developing mouse brain. Brain homogenates from C57Bl/
6J mice at different embryonic (E), postnatal (days after birth, P), and adult (age of months, Pm) stages, as indicated, were assayed by quantitative
real-time PCR using primers specific for TLR1–9, MyD88, and TRIF. Relative quantification was assessed by using the formula 2
2DCT and by normalizing
the amount of the target gene to the housekeeping gene GAPDH, whose expression levels were not significantly altered during brain development
(data not shown). Mean value of E13 was set to 1-fold induction, and mean values of all other ages were related to E13. Results are presented as mean
+/2 SEM. Statistical analysis was performed using the Kruskal-Wallis one-way analysis of variance with *p,0.05.
doi:10.1371/journal.pone.0037767.g001
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BCIP) of the C57Bl/6J cerebral neocortex and hippocampus on P12 (A, B) and of the C57Bl/6J cerebral neocortex of different ages (C, D), as indicated,
using probes specific for TLR7 (A, C), TLR9 (B, D), or a scrambled control probe. Insets in C and D display images of the neocortex with higher
magnification. (E) In situ hybridization (NBT/BCIP) of the P5m-old C57Bl/6J (WT), TLR7KO, and TLR9KO neocortex using probes specific for TLR7 or
TLR9, as indicated. In situ hybridization (Fast Red) of adjacent brain sections positive for TLR7 (on P12, F) or TLR9 (on P5m, G) co-immunostained with
NeuN antibody and visualized by an Alexa-568-conjugated secondary antibody (F) or by DAB staining (G), respectively. Scale bar, 50 mm. (*) marks
the skull.
doi:10.1371/journal.pone.0037767.g002
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the neocortex and hippocampus of adjacent brain sections by
DAB staining confirmed expression of TLR9 protein in axons
(Fig. 6C).
Specificity of the anti-TLR9 antibody was validated by
demonstrating its reactivity with HEK293 cells transfected with
TLR9 (Fig. 6D) and by analyzing comparable brain sections from
TLR9-deficient mice (Fig. 6E).
Since both TLR7 and TLR9 signal through MyD88 [3],
protein expression of this adaptor protein in the CNS was
investigated by additional immunostainings of brain sections
derived from different developmental stages (Fig. 6F). No distinct
signal was detected in brains from embryonic, postnatal, or adult
mice after treatment with an antibody directed against MyD88. In
contrast, spleen cells, which served as positive control, displayed
strong expression of MyD88, as expected. Specificity of the
employed antibody was confirmed by analyzing comparable
spleen sections from MyD88-deficient mice, in which no signal
for MyD88 was detected after immunostaining with the named
antibody (Fig. 6F).
Discussion
TLRs mediate both innate and adaptive immunity. They were
extensively studied as pathogen-recognition receptors in verte-
brates so far. Toll in Drosophila melanogaster is involved in
developmental processes that control the dorsoventral axis of the
fruit fly embryo, synaptogenesis, and axon path finding [1,13].
Such non-immune functions for TLRs are mostly unknown in
mammals, although these receptors are evolutionary highly
conserved across species, and evidence emerges that traditional
immune molecules may unfold distinct functions in neuronal
processes [14].
We show that distinct TLR family members are expressed in
specific temporal patterns during development of the mouse brain.
Expression profiles of TLR7 and TLR9 revealed time-dependent
regulation, whereas expression levels of the other tested TLRs and
the adaptor molecules MyD88 and TRIF did not change
significantly in the developing brain. Neurons of various brain
regions, in particular those in the neocortex and hippocampus,
were the main CNS cell type expressing TLR7 and TLR9 during
the analyzed period. Although the functional relevance of these
receptors for the developing CNS remains unknown, previous
work suggests a role for other TLR family members in various
aspects of neural development [15]. For example, TLR2 and
TLR4 in neural progenitor cells (NPC) may have an impact on
their proliferation and differentiation, and mice lacking TLR2
display impaired neurogenesis in the hippocampus [10]. TLR3
was described as a negative regulator of NPC proliferation and to
control axonal growth [7,8], and TLR8 is involved in apoptosis of
axons and neurons in the developing brain [9]. Thus, TLRs may
exert various functions in different developmental contexts.
Despite the reports cited above, only TLR7 and TLR9 were
significantly regulated during CNS development in our work. This
discrepancy might be explained, at least in part, by the use of
whole forebrains in our study, whereas distinct CNS regions were
investigated selectively in the previous works. We may have missed
subtle changes of expression patterns in our more holistic analysis.
In addition, differences regarding the analyzed time points and
mouse strains have to be considered when comparing studies on
TLR expression in developmental processes. For example,
whereas C57Bl/6J mice were used in our study, Ma and
colleagues have employed Swiss Webster mice in their work.
Also, the exact developmental stages analyzed in our study differ
from the time points chosen by the named group [9].
Our data demonstrate that TLR7 is not only expressed in
neuronal cell bodies but also in axons that were present in various
brain regions, partly bundled to tracts and partly nestled between
axons, which lacked TLR7. Although these structures were
morphologically judged as axons, they did not stain with
established antibodies directed against neurofilament or myelin
[16,17]. We hypothesize that these structures represent axonal
subtypes that appear only at specific developmental stages and
escape detection with established axonal markers. In accordance
with this hypothesis, these TLR7-positive axons were mainly
observed in the early postnatal phase important for CNS
morphogenesis but were absent or much less frequent in the adult
brain. Toll is involved in axon path finding in the fruit fly embryo
[13], and several reports discuss a role for TLRs in neurite
outgrowth in vertebrates [8,9]. It is therefore possible that the
TLR7-positive axons observed in our studies are involved in axon
path finding during development of the mouse brain.
TLR7 and TLR9 in immune cells recognize single-stranded
RNA and unmethylated CpG DNA from pathogens [3],
respectively, but the putative ligand for these TLRs in the context
of brain development remains unknown. Importantly, TLRs in
immune cells can respond to alterations in their immediate vicinity
by recognizing host-derived molecules including matrix compo-
nents, their degradation products, or molecules released from
injured cells [18,19]. It is conceivable that TLR-dependent control
of developmental processes in the CNS such as neurogenesis,
neurite outgrowth, or axon path finding occur as part of a
physiological response to tissue injury. Later in life, pathways
involved in development may be reactivated in response to injury.
One possibility is that TLR7 and TLR9 in the developing brain
Figure 3. TLR7 protein is expressed in various regions of the
mouse brain. Brain sections of P12 C57Bl/6J mice were incubated with
an antibody against TLR7 and stained with DAB (A, overview). Cutouts
from various brain regions including hippocampus (B), parietal
neocortex (C), reticular thalamic nucleus (D), piriform cortex (E), and
posterio-medial cortical amygdala (F) are shown. Scale bars, a: 500 mm;
b, c, d, f:5 0mm, e: 100 mm.
doi:10.1371/journal.pone.0037767.g003
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instead by pathogen-associated RNA or DNA in infectious
situations. The exact source and localization of such endogenous
ligands during brain development remains to be determined. It is
unknown whether the respective ligand is released from the
neurite itself and acts through an autocrine mechanism or
originates from the target structure, thereby guiding neurons
expressing the matching TLR. Since TLR7 and TLR9 localize to
endosomes, at least in immune cells [3], the involved ligands
would have to enter the neuron to bind to the respective TLR.
Also the intracellular signaling cascade involved in TLR signaling
during development in vertebrates remains to be elucidated. In
contrast to TLR7 and TLR9, expression of the intracellular
adaptors MyD88 and TRIF was unaltered during brain develop-
ment in our study. This result is consistent with the previous
finding that the TLR8-mediated response in neurons does not
involve the canonical TLR-NF-kB signaling pathway in the
context of brain development [9]. In accordance with this, mice
deficient of both MyD88 and TRIF and therefore lacking the
established signaling pathways downstream of TLRs do not seem
to be grossly impaired in terms of CNS development [20]. One
candidate signaling molecule among others is the adaptor
molecule sterile-alpha- and armadillo-motif-containing protein
(SARM), which is preferentially expressed in neurons and
regulates neuronal survival [21].
The finding that TLR7 and TLR9 are prominently and time-
dependently expressed in the developing brain must also be
discussed in the context of infections. Perinatal expression of
TLR7 in neurons and glia may influence the receptiveness and the
responsiveness of the developing brain to viral infections, which in
turn may play a role in the etiology of neurodevelopmental
disorders including autism and schizophrenia [22,23,24]. The
impact of TLR activation on developmental processes may depend
on the state of the local environment, i.e. physiological versus
pathological conditions. This hypothesis is supported by the fact
that TLRs are expressed in glial cells in the neurogenic niches of
the adult brain, and immune responses are suggested to affect
hippocampal neurogenesis [25,26,27].
In summary, we show that TLR7 and TLR9 undergo
significant regulation during development of the murine brain,
whereas no corresponding changes were observed for the
expression of other TLR family members. This finding supports
a role for TLRs in brain development in vertebrates in general and
for a specific role for TLR7 and TLR9. However, mice deficient
for a single TLR or combinations of two TLRs are viable.
Although their brains have not been investigated in detail on a
microanatomic level, no major impairment in CNS development
resulting in morphogenetic failures in these animals was described
[28,29]. Thus, a single TLR may not be irreplaceable during
development of the CNS. Since the TLR family exerts high
redundancy in the immune system [30], allowing various TLRs to
Figure 4. Expression of TLR7 protein in the developing mouse brain. (A) Immunostaining of the neocortex from C57Bl/6J mice with an
antibody against TLR7 at different developmental stages, as indicated. Scale bar, 100 mm. (B) Adjacent brain sections from P12 mice were co-
immunostained with antibodies against TLR7 and NeuN and analyzed by confocal sequential microscopy. Scale bar, 50 mm. (C) HEK293 cells
transfected with pCAG-TLR7-IRES-eGFP and pCAG-IRES-eGFP were used as positive and negative control for immunostaining with the anti-TLR7
antibody, respectively. (E) Brain sections from P12 C57Bl/6J and TLR7KO mice were immunostained with the antibody against TLR7 named above and
DAPI. Scale bar, 50 mm.
doi:10.1371/journal.pone.0037767.g004
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tion of animals lacking whole functional groups of TLRs, such as
TLR3, TLR7, and TLR9 might be required to understand the
TLRs’ role in the specific context of development. Also, other
pathways downstream of TLRs besides the established ones that
signal through MyD88 or TRIF may have to be considered and
identified to gain deeper insight into the pathophysiological
significance of TLRs in the development of the vertebrate brain.
Materials and Methods
Mice and cell lines
C57Bl/6J (WT) mice were purchased from Charles River,
Sulzbach, Germany. TLR7 knock out (KO), TLR9KO, and
MyD88KO mice were generously provided by Dr. S. Akira
(Osaka University, Department of Host Defense, Osaka, Japan).
All animals received humane care according to institutional
criteria. All animal procedures were approved by the Landesamt
fu ¨r Gesundheit und Soziales Berlin (LAGeSo registration T0046/
02). HEK293 cells were provided by American Type Culture
Collection, Manassas, VA, and were cultured in DMEM
supplemented with 10% heat-inactivated FCS and penicillin-
streptomycin. Cells were grown at 37uC in humidified air with 5%
CO2.
Immunocytochemistry and immunohistochemistry
Immunostainings were performed as described previously [19].
The following primary antibodies were used: anti-neuronal-
specific nuclear protein NeuN, anti-neurofilament, anti-microtu-
bule-associated protein (MAP-2), anti-glial fibrillary acidic protein
(GFAP), anti-MyD88 (C-terminus), and anti-RIP (anti-oligoden-
drocytes, clone NS-1); all purchased from Millipore, Billerica, MA.
anti-TLR7 and anti-TLR9 were purchased from Imgenex, San
Diego, CA; anti-Iba1 was from Wako, Neuss, Germany.
Fluorescence microscopy was performed using an Olympus
BX51 microscope and a confocal laser scan Leica TCS SL
microscope with sequential analysis. For DAB (3,39-diaminoben-
zidine) staining incubation with the primary antibody was followed
Figure 5. Axons express TLR7 during development of the brain. (A) Immunostaining of brain sections from C57Bl/6J mice on P12 and P5m
using an antibody against TLR7. An overview and higher magnification images (*, **, ***, ****) displaying TLR7 expression in various brain regions are
shown. CPu: caudate putamen; LSD: dorso-lateral septum; ff: fimbria, fornix; cc: corpus callosum. (B) Brain sections from P12 mice were co-
immunostained with antibodies against TLR7 and neurofilament and subsequently were analyzed by confocal sequential microscopy. An overview
and a higher magnification image (*) displaying TLR7 expression in the striatum are shown. Scale bar, 100 mm. (C) Brain sections from P12 mice were
co-immunostained with antibodies against TLR7 and GFAP, RIP, or Iba1 to mark astrocytes, oligodendrocytes, and microglia in the corpus callosum,
respectively. Subsequently, immunostained brain sections were analyzed by confocal sequential microscopy. Scale bar, 10 mm.
doi:10.1371/journal.pone.0037767.g005
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with the appropriate biotinylated secondary antibody (Vector
Laboratories, Burlingame, CA) diluted 1:250 in 0.1 M PB for 1 h.
Visualization of antibody binding by DAB staining was performed
using the ABC Standard Kit (Vector Laboratories) with DAB/
H2O2 as substrates following the manufacturer’s suggestions.
In situ hybridization
In situ hybridization of mouse brain cryostat sections of different
ages, as indicated, using probes specific for TLR7 (59-TAATCA-
CATCCACTTTTTCATC-39) or TLR9 (59-GGTCCAGT-
TAAAGAAAGATAGGT-39) and a scrambled control probe (59-
GTGACACGTCTATACGCCCA-39) synthesized by Exiqon,
Vedbaek, Denmark, was visualized by Fast Red or NBT/BCIP
and was performed as described previously [31].
Quantitative real-time RT-PCR
Native brains were isolated from C57BL/6J mice and tissue of
the telencephalon and diencephalon of the same developmental
stage (E13, E14, E15, E16, E17, E18, E19, P0, P4, P8, P12, P5m,
Figure 6. Expression of TLR9 protein in the developing brain. (A) Immunostaining of the neocortex and hippocampus with an antibody
against TLR9 on P12 and P5m. AuV: secondary auditory cortex, CA1: cornu ammonis 1. Scale bar, 100 mm. (B) Brain sections from P5m C57Bl/6J mice
were co-immunostained with antibodies against TLR9 and MAP-2, and the hippocampus was analyzed by confocal sequential microscopy. (C)
Adjacent brain sections were incubated with an antibody against TLR9 and stained with DAB. Scale bar, 100 mm (upper images) and 50 mm (lower
image). (D) HEK293 cells co-transfected with TLR9 and a DsRed vector served as positive control for immunostaining with the anti-TLR9 antibody.
Transfection with the DsRed vector alone was used as negative control. (E) Brain sections from P5m-old C57Bl/6J (WT) and TLR9KO mice were
immunostained with the antibody against TLR9 named above and DAPI. (F) Brain sections from E16-, P12-, and P5m-old WT mice were
immunostained with an antibody against MyD88 and with DAPI. Spleen sections from P5m-old WT and MyD88KO mice served as positive and
negative control for immunostaining with the anti-MyD88 antibody, respectively. Scale bar, 50 mm.
doi:10.1371/journal.pone.0037767.g006
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nitrogen. mRNA was prepared using the Absolutely RNA
Miniprep Kit (Stratagene, La Jolla, CA) and reversely transcribed
to cDNA by a murine leukemia virus reverse transcriptase (Gibco,
Karlsruhe, Germany). Expression of Toll-like Receptors 1–9,
MyD88, TRIF, and GAPDH was analyzed by quantitative real-
time PCR using specific primers for the respective candidate
molecule and the SYBR Green dye as the fluorescent reporter
(n=3, Super Array, Frederick, MD). PCR reactions were
performed with 1 mg of cDNA using an ABI PRISM 7500 Fast
Lightcycler (Applied Biosystems, Foster City, CA). Relative
quantification was assessed by using the formula 2
2DCT and by
normalizing the amount of the target gene to the housekeeping
gene GAPDH.
RNA degradation was ruled out by testing the respective RNA
preparations on denaturing agarose gels. All gel runs resulted in
sharp 18S and 28S rRNA bands. Also, the 28S rRNA band was
constantly approximately twice as intense as the 18S rRNA band
indicating that the tested RNA was intact (data not shown).
Statistical analysis
Quantitative real-time RT-PCR data were analyzed using the
Kruskal-Wallis Test (GraphPad Prism 5.00, GraphPad Software,
San Diego, CA). Differences were considered statistically signifi-
cant with p,0.05.
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